Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle.

Lindsay A, Larson AA, Verma M, Ervasti JM, Lowe DA.

J Appl Physiol (1985). 2019 Feb 1;126(2):363-375. doi: 10.1152/japplphysiol.00948.2018. Epub 2018 Dec 20.

PMID:
30571283
2.

Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.

Lindsay A, Schmiechen A, Chamberlain CM, Ervasti JM, Lowe DA.

Exp Physiol. 2018 Jul;103(7):995-1009. doi: 10.1113/EP087031.

3.

Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.

Capogrosso RF, Mantuano P, Cozzoli A, Sanarica F, Massari AM, Conte E, Fonzino A, Giustino A, Rolland JF, Quaranta A, De Bellis M, Camerino GM, Grange RW, De Luca A.

J Appl Physiol (1985). 2017 Apr 1;122(4):828-843. doi: 10.1152/japplphysiol.00776.2015. Epub 2017 Jan 5.

4.

Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle.

Blaauw B, Mammucari C, Toniolo L, Agatea L, Abraham R, Sandri M, Reggiani C, Schiaffino S.

Hum Mol Genet. 2008 Dec 1;17(23):3686-96. doi: 10.1093/hmg/ddn264. Epub 2008 Aug 27.

PMID:
18753145
5.

Restoration of pharyngeal dilator muscle force in dystrophin-deficient (mdx) mice following co-treatment with neutralizing interleukin-6 receptor antibodies and urocortin 2.

Burns DP, Rowland J, Canavan L, Murphy KH, Brannock M, O'Malley D, O'Halloran KD, Edge D.

Exp Physiol. 2017 Sep 1;102(9):1177-1193. doi: 10.1113/EP086232. Epub 2017 Aug 6.

6.

Adaptive strength gains in dystrophic muscle exposed to repeated bouts of eccentric contraction.

Call JA, Eckhoff MD, Baltgalvis KA, Warren GL, Lowe DA.

J Appl Physiol (1985). 2011 Dec;111(6):1768-77. doi: 10.1152/japplphysiol.00942.2011. Epub 2011 Sep 29.

7.

Variable cytoplasmic actin expression impacts the sensitivity of different dystrophin-deficient mdx skeletal muscles to eccentric contraction.

Lindsay A, Southern WM, McCourt PM, Larson AA, Hodges JS, Lowe DA, Ervasti JM.

FEBS J. 2019 Jul;286(13):2562-2576. doi: 10.1111/febs.14831. Epub 2019 Apr 11.

PMID:
30942954
8.

Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.

Capogrosso RF, Mantuano P, Uaesoontrachoon K, Cozzoli A, Giustino A, Dow T, Srinivassane S, Filipovic M, Bell C, Vandermeulen J, Massari AM, De Bellis M, Conte E, Pierno S, Camerino GM, Liantonio A, Nagaraju K, De Luca A.

FASEB J. 2018 Feb;32(2):1025-1043. doi: 10.1096/fj.201700182RRR. Epub 2018 Jan 3.

9.
10.

Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.

Church JE, Trieu J, Chee A, Naim T, Gehrig SM, Lamon S, Angelini C, Russell AP, Lynch GS.

Exp Physiol. 2014 Apr;99(4):675-87. doi: 10.1113/expphysiol.2013.077255. Epub 2014 Jan 17.

11.

Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.

Boulanger Piette A, Hamoudi D, Marcadet L, Kyomi Labelle F, Ovidiu David R, Bossé S, Argaw A, Frenette J.

PLoS One. 2018 Jun 7;13(6):e0198408. doi: 10.1371/journal.pone.0198408. eCollection 2018.

12.

Acute failure of action potential conduction in mdx muscle reveals new mechanism of contraction-induced force loss.

Call JA, Warren GL, Verma M, Lowe DA.

J Physiol. 2013 Aug 1;591(15):3765-76. doi: 10.1113/jphysiol.2013.254656. Epub 2013 Jun 10.

13.

Sustained improvement of muscle function one year after full-length dystrophin gene transfer into mdx mice by a gutted helper-dependent adenoviral vector.

Dudley RW, Lu Y, Gilbert R, Matecki S, Nalbantoglu J, Petrof BJ, Karpati G.

Hum Gene Ther. 2004 Feb;15(2):145-56.

PMID:
14975187
14.

Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy.

Dufresne SS, Boulanger-Piette A, Bossé S, Argaw A, Hamoudi D, Marcadet L, Gamu D, Fajardo VA, Yagita H, Penninger JM, Russell Tupling A, Frenette J.

Acta Neuropathol Commun. 2018 Apr 24;6(1):31. doi: 10.1186/s40478-018-0533-1.

15.

Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice.

Mueller GM, O'Day T, Watchko JF, Ontell M.

Hum Gene Ther. 2002 Jun 10;13(9):1081-90.

PMID:
12067441
16.

Truncated dystrophins reduce muscle stiffness in the extensor digitorum longus muscle of mdx mice.

Hakim CH, Duan D.

J Appl Physiol (1985). 2013 Feb 15;114(4):482-9. doi: 10.1152/japplphysiol.00866.2012. Epub 2012 Dec 6.

17.

Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy.

Carberry S, Brinkmeier H, Zhang Y, Winkler CK, Ohlendieck K.

Int J Mol Med. 2013 Sep;32(3):544-56. doi: 10.3892/ijmm.2013.1429. Epub 2013 Jul 3.

18.

Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse tibialis anterior muscle.

Sacco P, Jones DA, Dick JR, Vrbová G.

Clin Sci (Lond). 1992 Feb;82(2):227-36.

PMID:
1311662
19.

Dystrophin expression following the transplantation of normal muscle precursor cells protects mdx muscle from contraction-induced damage.

Rousseau J, Dumont N, Lebel C, Quenneville SP, Côté CH, Frenette J, Tremblay JP.

Cell Transplant. 2010;19(5):589-96. doi: 10.3727/096368910X4863235.

PMID:
20650035
20.

Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.

Whitehead NP, Bible KL, Kim MJ, Odom GL, Adams ME, Froehner SC.

J Physiol. 2016 Dec 15;594(24):7215-7227. doi: 10.1113/JP272707. Epub 2016 Oct 13.

Supplemental Content

Support Center